BioNJ Annual Dinner Meeting Committee

BioNJ Members collaborate to plan the agenda for the February BioNJ Annual Dinner Meeting and Innovation Celebration; a celebratory dinner meeting and networking event honoring New Jersey’s innovators and the Patients who inspire them.

Committee Members:

Co-Chairs
Marsh, Inc. – Bill DeStefano, Vice President, Life Science Practice
VelocIT – Darek Hahn, President & CEO

Amicus Therapeutics, Inc. – Jayne Gershkowitz, Chief Patient Advocate
Amicus Therapeutics, Inc. – Paul Howard, PhD – Director of Public Policy
Ashton Tweed, LTD – Jordan Warshafsky, MBA, Partner
Bristol Myers Squibb CompanyEthan Hasbrouck, State Government Affairs
Chemical & Pharmaceutical Solutions
– James Bruno, MBA, Managing Director
Deloitte – Brian Wilcomes, CPA, Partner
Eli Lilly & Company – Tracy Henrikson, MBA, Vice President, Corporate Communications
EY – Tony Torrington, CPA, Partner
EY – Joel Wagner, CPA, Assurance Senior Manager
GenmabMarisol Mendez Peron, Senior Vice President, Global Investor Relations & Communications
Infinity Resources, LLC
– Harriet Maphet, MBA, President
Insmed Incorporated – Mandy Fahey, Senior Director, Corporate Communications
Janssen Pharmaceuticals – Ebony Staton Weidman, Senior Manager, State Public Affairs & Access Communications
Jones Lang LaSalle – John Cahill, Senior Vice President
LeaderStrong – Marshall Calman, MBA, PCC, Co-Founder & Principal
LeaderStrong – Jack Levitt, MBA, EMTM, Co-Founder & Principal
Merck & Co., Inc. – Andrew H. Latham, Ph.D., Director, Enabling Technologies Business Development
New Jersey Commission of Science, Innovation & Technology  – Judith Sheft, MSc, MBA, Executive Director
Sanofi – Angela Bechan, Vice President, Head of Communications & Corporate Social Responsibility, North America
Soligenix, Inc. – Christopher Schaber, Ph.D., President & CEO